X4 Pharmaceuticals (XFOR) Earnings Date, Estimates & Call Transcripts $4.12 -0.11 (-2.60%) Closing price 04:00 PM EasternExtended Trading$4.11 -0.01 (-0.24%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock X4 Pharmaceuticals Earnings Summary X4 Pharmaceuticals released Q2 2025 earnings on August 8, 2025, reporting an EPS of -$3.47, which beat the consensus estimate of -$4.53 by $1.06. Quarterly revenue was reported to be $1.97 million, above the consensus estimate of $1.62 million. With a trailing EPS of -$14.84, X4 Pharmaceuticals' earnings are expected to grow next year, from ($0.68) to ($0.51) per share. Upcoming Q3 Earnings DateNov. 12Before Market OpensEstimatedConsensus EPS (Aug. 8) -$4.53 Actual EPS (Aug. 8) -$3.47 Beat By $1.06 Actual Revenue (Aug. 8) $1.97MQ2 2025 Earnings ResourcesQ2 2025 Earnings Report Quarterly Report (10-Q)XFOR Upcoming EarningsX4 Pharmaceuticals' next earnings date is estimated for Wednesday, November 12, 2025, based on past reporting schedules. Powered by Get X4 Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on X4 Pharmaceuticals and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataXFOR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.XFOR Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. X4 Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.60-$0.60-$0.60Q2 20251-$3.90-$3.90-$3.90Q3 20251-$0.42-$0.42-$0.42Q4 20251-$0.33-$0.33-$0.33 FY 2025 4 -$5.25 -$5.25 -$5.25 Q1 20261-$0.31-$0.31-$0.31Q2 20261-$0.31-$0.31-$0.31Q3 20261-$0.31-$0.31-$0.31Q4 20261-$0.22-$0.22-$0.22 X4 Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/12/2025(Estimated)--------8/8/2025Q2 2025-$4.53-$3.47+$1.06-$3.47$1.62M$1.97M5/1/2025Q1 2025-$4.13$0.04+$4.17$0.04$7.03M$28.81M3/25/2025Q4 2024-$5.10-$6.00 -$0.90-$0.20$1.07M$1.43M8/14/2024Q2 2024-$0.30-$0.01-$3.43M8/8/2024Q2 2024-$1.20-$2.10 -$0.90-$0.59$52.98M$0.56M5/14/2024Q1 2024--$15.00--$0.50-$0.73M5/7/2024Q1 2024-$5.10-$7.80 -$2.70-$0.26--3/26/2024Q4 2023--$20.10--$0.67-$1.02M3/21/2024Q4 2023-$4.50-$3.00+$1.50-$0.10--11/14/2023Q3 2023--$9.60--$0.32-$0.85M Get the Latest News and Ratings for XFOR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for X4 Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/9/2023Q3 2023-$4.50-$0.30+$4.20-$0.01-- X4 Pharmaceuticals Earnings - Frequently Asked Questions When is X4 Pharmaceuticals' earnings date? X4 Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 12th, 2025 based off last year's report dates. Learn more on XFOR's earnings history. Did X4 Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, X4 Pharmaceuticals (NASDAQ:XFOR) reported ($3.47) earnings per share (EPS) to beat the analysts' consensus estimate of ($4.53) by $1.06. Learn more on analysts' earnings estimate vs. XFOR's actual earnings. How much revenue does X4 Pharmaceuticals generate each year? X4 Pharmaceuticals (NASDAQ:XFOR) has a recorded annual revenue of $2.56 million. How much profit does X4 Pharmaceuticals generate each year? X4 Pharmaceuticals (NASDAQ:XFOR) has a recorded net income of -$37.45 million. XFOR has generated -$14.84 earnings per share over the last four quarters. What is X4 Pharmaceuticals' EPS forecast for next year? X4 Pharmaceuticals' earnings are expected to grow from ($0.68) per share to ($0.51) per share in the next year. More Earnings Resources from MarketBeat Related Companies Immuneering Earnings Results Nuvectis Pharma Earnings Results Actuate Therapeutics Earnings Results Caribou Biosciences Earnings Results Seres Therapeutics Earnings Results Nkarta Earnings Results Kyverna Therapeutics Earnings Results Black Diamond Therapeutics Earnings Results Greenwich LifeSciences Earnings Results BioAge Labs Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor After Earnings Miss, Walmart Is Still a Top Consumer Staples PlayRoyal Caribbean Earnings Beat Fuels Strong 2025 OutlookDLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost Pressures This page (NASDAQ:XFOR) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding X4 Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share X4 Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access